The Efficacy of Dexmedetomidine and Magnesium Sulfate in Cognitive Dysfunction

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

Magnesium sulfate is considered a neuroprotective drug and has been studied in various applications. Recently, it has drawn the attention of anesthesiologists, resulting in numerous publications about its role in anesthesiology. Magnesium sulfate is suggested to exert its neuroprotective effect by preventing excitotoxicity. in the clinical setting, intraoperative magnesium sulfate attenuated POCD. Furthermore, postoperative emergence agitation was significantly reduced in pediatric patients who received intraoperative magnesium sulfate during adenotonsillectomy. The aim of this study The aim of this work is to compare the protective effect of intraoperative dexmedetomidine with magnesium sulfate against developing POCD and to study their effect on serum level of CRP; the marker of neuronal degeneration.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 60
Maximum Age: 80
Healthy Volunteers: f
View:

• ASA physical status I, II and ⅠⅠⅠ

• patients undergoing open abdominal surgery under general anesthesia

Locations
Other Locations
Egypt
Dexmedetomidine
RECRUITING
Al Fayyum
Contact Information
Primary
Mohamed Ahmed Hamed, MD
mah07@fayoum.edu.eg
01010509736
Time Frame
Start Date: 2024-11-21
Estimated Completion Date: 2025-05-15
Participants
Target number of participants: 58
Treatments
Active_comparator: The dexmedetomidine
29 patients will receive a bolus dose of dexmedetomidine (0.5 μg kg-1) over 10 minutes before induction followed by an infusion (0.3 μg kg-1 h-1), which will be discontinued at the skin closure.
Active_comparator: The magnesium sulfate
29 patients will receive 20 mg/kg as loading dose over 10 minutes before induction then maintenance dose 5 mg/kg/hour, which will also be discontinued at the skin closure
Related Therapeutic Areas
Sponsors
Leads: Fayoum University

This content was sourced from clinicaltrials.gov